SuperworthEton Pharmaceuticals shares outstanding ETON
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 32.8M
- On a year earlier
- +21.9%
- more shares
Eton Pharmaceuticals had 32.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 21.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2021 | 25.3M | +6% |
| FY2020 | 23.8M | +33% |
| FY2019 | 17.9M | +54% |
| FY2018 | 11.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 32.8M | +22% | |
| Q1 FY26 | 31.5M | +17% | |
| Q3 FY25 | 26.9M | +1% | |
| Q2 FY25 | 26.9M | +4% | |
| Q1 FY25 | 26.9M | +4% | |
| Q3 FY24 | 26.6M | +3% | |
| Q2 FY24 | 25.8M | −1% | |
| Q1 FY24 | 25.8M | +1% | |
| Q3 FY23 | 25.7M | +1% | |
| Q2 FY23 | 26M | +3% | |
| Q1 FY23 | 25.5M | +1% | |
| Q3 FY22 | 25.4M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Eton Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.